Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype

URN:NBN:SI:doc-HLHV2EXE2016Virijevic, Marijanadocuments/doc/H/URN_NBN_SI_doc-HLHV2EXE_001.pdfdocuments/doc/H/URN_NBN_SI_doc-HLHV2EXE_001.txt450articlestr. 385-393, IV1318-2099288599296URN:NBN:SI:doc-HLHV2EXEengAssociation of Radiology and OncologyRadiology and oncology (Ljubljana)BYlevkemijamutacije genovnapovedni dejavnikiSomatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype